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Abstract
Breath analysis holds great promise for real-time and non-invasivemedical diagnosis. Thus, there is a
considerable need for simple-in-use and portable analyzers for rapid detection of breath indicators for
different diseases in their early stages. Sensor technologymeets all of these demands. However,
miniaturized breath analyzers require adequate breath samplingmethods. In this context, we propose
non-contact sampling; namely the collection of breath samples by exhalation from a distance into a
miniaturized collector without bringing themouth into direct contact with the analyzing device. To
evaluate this approach different breathingmaneuvers have been tested in a real-time regime on a
cohort of 23 volunteers using proton transfer reactionmass spectrometry. The breathingmaneuvers
embraced distinct depths of respiration, exhalationmanners, size of themouth opening and different
sampling distances. Two inhalationmodes (normal, relaxed breathing and deep breathing) and two
exhalationmanners (via smaller andwider lips opening) forming four sampling scenarios were
selected. A sampling distance of approximately 2 cmwas found to be a reasonable trade-off between
sample dilution and requirement of no physical contact of the subject with the analyzer. All four
scenarios exhibited comparablemeasurement reproducibility spread of around 10%. For normal,
relaxed inspiration both dead-space and end-tidal phases of exhalation lasted approximately 1.5 s for
both expiration protocols. Deep inhalation prolongs the end-tidal phase to about 3 s in the case of
blowing via a small lips opening, and by 50%when the air is exhaled via awide one. In conclusion,
non-contact breath sampling can be considered as a promising alternative to the existing breath
samplingmethods, being relatively close to natural spontaneous breathing.
1. Introduction
Volatile organic compounds (VOCs) produced by a
human organism mirror normal and abnormal bio-
chemical processes occurring in the body [1–5]. Their
analysis in exhaled air, or other bodily fluids such as
urine, sweat, or saliva has, therefore, a great potential
for medical diagnosis and therapy monitoring [3].
These compounds are commonly defined as the
human volatilome [6], and they can have a systemic
origin or stem from exogenous sources such as diet,
environmental exposure, or microbiota activity. The
disease state influences the normal VOCs profile by
generating new species or altering the concentrations
of the VOCs that are produced by the organism [3–5].
The detection of this alteration, via e.g. breath analysis,
provides a unique and non-invasive tool for tracking
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processes or exposure to environmental tox-
ins [3, 7, 8].
Reliability and reproducibility of sampling is prob-
ably one of the most demanding challenges in breath
gas analysis. A number of different factors related to
this phase of analysis can affect the levels of breath spe-
cies. These embrace factors such as body posture
[9, 10], exercise/body movement [10, 11], breathing
mode (e.g. breath holding, depth of respiration) [12],
exhalation routes (nose versus mouth) [13], or expo-
sure to variable environmental, or dietary con-
taminants. Moreover, analysis-related phenomena,
e.g. pollutants, losses, dilution and interactions with
instrument materials, can irreversibly modify the ori-
ginal sample composition and consequently distort
the disease-related chemical fingerprint. Ultra-low
concentrations of volatile breath constituents (from
ppb to low ppt), the presence of highly reactive species
and the high humidity of breath samples inducing wet
chemistry pose additional challenges and problems.
Currently, there is no commonly accepted stan-
dard for breath sampling and numerous approaches
are proposed in the literature. Typically, the end-tidal
phase of exhalation is targeted as it shows the highest
concentrations of systemic species and the lowest
levels of exogenous compounds (produced e.g. in the
oral cavity) [14]. The end-tidal sampling is usually
accomplished by the measurement of expired CO2
concentrations, measurement of exhaled airflow, or
use of buffer volumes collecting the last phase of exha-
lation [10, 15–19]. Breath sampling can be also per-
formed for a single breath or for multiple breath
cycles. Usually, breath samplers impose the use of dis-
posable mouthpieces assisting the flow of the breath
stream into a sampler leading into the analytical
instrument or the use of a storage container [15–17].
These standardize some sampling conditions (e.g.
resistance during exhalation, diameter of breath
stream) and isolates the sample from the roomair con-
taminants, but they also cause issues. For example,
breath samplers have to be periodically cleaned and
sterilized. Moreover, a mouthpiece can also be a
source of contaminants if it is not inert it can promote
losses of VOCs from the breath sample or can add
VOCs coming from thematerials of the samplers. Fur-
thermore, breath samplers are usually relatively large-
in-size and energy-consuming (heating systems,
flow/pressure/CO2 sensors) and are, therefore, of
limited use inminiaturized devices.
When it comes to sensors used for breath analysis,
the main technological challenge is the requirement
for trace-amount (at least ppb) detection of marker
compounds in the presence of real world confounding
factors. Factors such as the chemical or physical
instability of both breath samples and sensing ele-
ments as well as the variation of VOC background and
humidity impose numerous problems for stable ana-
lysis of real-world breath samples. The process of sam-
pling exhaled breath and preparing it for delivery to
the sensors through a sampling inlet system can intro-
duce contamination or lead to the loss of target VOCs.
On the other hand, the currently available real-time
breath collection methods are rather bulky and heavy
[15, 19], and are thus unsuitable for breath collection
with sensor-basedminiaturized analyzers.
Within this study a different sampling approach
has been investigated: a collection of breath samples by
exhalation from a distance without bringing the
mouth into direct contact with a sample inlet of the
breath analyzer. This concept can simplify the design
of the analyzer and eliminate the use of disposable
mouthpieces, while preserving high patient safety and
comfort. To investigate this approach, proton transfer
reaction mass spectrometry (PTR-MS) has been
applied. Within this study PTR-MS mimicked minia-
turized breath analyser, while providing the real-time
response, selectivity and sensitivity necessary to moni-
tor prototypic breath VOCs with a breath-to-breath
resolution [20].
2.Methods
2.1.Human subjects and sampling protocol
A cohort of 23 healthy subjects (10 males and 13
females, age range 22–59 years, body mass index
(BMI) range 18.5–29.8 (median 23.1), 5 of whomwere
smokers) was recruited. An effort was made to enroll
volunteers unfamiliar with breath sampling. All
volunteers gave written informed consent to partici-
pate and completed a questionnaire describing their
basic personal data and smoking status. The measure-
ments were performed under fasting conditions
(minimumof 12 h).Moreover, the subjects were asked
to refrain from alcohol consumption for 12 h prior to
the experiments, smoking for 2 h and from using
cosmetics/fragrances and breath mints/chewing
gums on the day of the test. Furthermore, the subjects
were asked to sit quietly for 10 min prior the test to
avoid any temporal changes in levels of breath VOCs
related to body movement, as occurs for example with
isoprene [10, 11]. The sample collection was approved
by the Ethics Commission of Innsbruck Medical
University.
2.2. Breath sampling setup
Volunteers were advised to place his/her chin on a
special head holder firmly fixed on the table, as shown
in figure 1. The holder stabilized the position of the
subject head and mouth and facilitated precise and
reproducible positioning of the breath collector. The
height of the holder could be adjusted to provide the
most comfortable position for the subject. The inlet of
the PTR-MS instrument was mounted on another
adjustable holder, so its position and distance from the
volunteer’s lips could be smoothly adjusted in
response to the test requirements. The subjects were
asked to perform 5 sequential exhalations for every
2
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breathing scenario being tested. Four compounds
commonly found in human breath were monitored:
acetone, isoprene, methanol and dimethyl sulfide
(DMS). These compounds were selected because this
set of species embraces representatives of hydrophilic
(acetone, methanol), hydrophobic (isoprene) and
reactive (dimethyl sulfide) compounds.
Two inhalation and two exhalation maneuvers
were pre-selected for the tests. The selected inhalation
modes embrace (i) normal, relaxed breathing invol-
ving only the tidal volume of the lungs and (ii) deep
breathing without breath holding involving also
inspiratory reserve volume (denoted later in the text as
N and D modes, respectively). For the deep breathing
mode, the subjects were advised to inhale as much air
as they could and immediately blow towards the inlet.
Regarding exhalation scenarios, individuals were
asked to form with their lips a circular opening and
keep this shape during blowing. For the first exhala-
tionmode, subjects blew using an opening of approxi-
mately 1 cm in diameter; whereas the second
exhalation required the lips forming a wider opening
(comparable to lips’ shape during breathing on a cold
mirror to make water vapor condense). These exhala-
tionmodes will be denoted later in the text as S andW,
respectively. Subjects practiced several times the for-
mation of opening and subsequent blowing before any
measurements were taken. Moreover, the subjects
were asked to exhale quietly to avoid rapid exhalation
hindering the time of sample collection. Effectively,
two inhalation modes and two exhalation modes
formed four breathing scenarios denoted later in this
paper as NS, NW, DS and DW. The aforementioned
breathing maneuvers were selected from the ease of
understanding of the sampling protocol and their per-
ception by the volunteers.
To evaluate the influence of the sampling distance
the subjects were asked to blow at the sampling inlet
from four preselected distances of approximately 2, 5,
7.5 and 10 cm, while having their lips positioned in
the central axis of the transfer line inlet. The sampling
distance was adjusted exclusively by moving the
holder stabilizing the inlet.
2.3. PTR-TOF-MS analysis
An Ionicon Analytik GmbH (Innsbruck, Austria)
proton transfer reaction time of flight (TOF) mass
spectrometer (PTR-TOF-MS) instrument (PTR TOF
8000)was used for real-time analyses. Proton-transfer
reaction mass spectrometry is a well-established
sensitive analytical technique for the quantification of
molecular species down to the ppt range [21, 22]. Its
success stems from its versatility, excellent sensitivity
and rapid real-time response. In particular, the last
feature opens up a new fascinating opportunity of
tracking rapid short-time changes in breath VOC
concentrations with a breath-by-breath resolution
[10, 11]. In brief, PTR-MS offers a quantification of
volatile molecular species at ultra-low levels on the
basis of chemical ionization within a drift reactor tube.
More specifically, it exploits the proton transfer
reaction of precursor hydronium ions (H3O
+), origi-
nating from a hollow cathode discharge, with mole-
cules of interestM:
H O M MH H O.3 2+  ++ +
The aforementioned reaction process is facile for
VOCs with proton affinities higher than water
(166.5 kcal mol−1). A favorable consequence of the
employment of this ionization mechanism is the fact
that the bulk components of breath gas O2, N2, and
CO2 do not react with H3O
+. The only issue with
breath is its high humidity, which changes the
Figure 1.Experimental setup for non-contact sampling tests.
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humidity in the reaction chamber leading to higher
concentrations of protonatedwater clusters. However,
at the high reduced electric fields generally used
(∼130 Td), this is not a significant problem. The count
rates of the nascent product ions MH+ can subse-
quently be converted into absolute concentrations of
M. A major hallmark of the PTR-MS technique is its
near real-time response (100 ms) allowing for con-
centration measurements of VOCs with breath-by-
breath resolution. Moreover, the real-time analysis
improves the quality and reliability of the results, since
sample collection, storage and pre-concentration that
can result in contamination and losses of trace breath
VOCs are avoided. The application of a TOF mass
analyser in PTR-MS instruments provides increased
mass resolving power (4000 m/Δm or better) com-
pared to quadrupole mass spectrometer analysers, and
thereby provides the discrimination between many
isobaric compounds.
The breath samples were collected using a plain
disc-shaped inlet (OD=25mm) made from poly-
etheretherketone (PEEK) and equipped with a 1mm
orifice located in the center of the disc. From this inlet,
the breath samples were transferred into the drift tube
of the PTR-TOF 8000 via a sampling line comprising of
a heated (60 °C) PEEK tube (1.4m long, ID=1mm).
The inlet of the tube was equipped with a Luer-lock
port. The transfer line facilitated rapid transport of the
breath sample to the MS. The pumping rate via the
transfer linewas set at 4 ml s−1.
The PTR-TOF 8000 settings during experiments
were as follows: ion source current 4 mA, source volt-
age 120 V, source-out voltage 50 V, and source valve
opening 55%. With these settings the levels of the
major impurity ions relative to that of the H3O
+ pre-
cursor ion were H3O
+.H2O (3%), O2
+ (2.7%), and
NO+ (0.3%). The H3O
+/VOCs reactions occurred in
the drift tube at a total pressure of 2.4 mbar and a gas
temperature of 60 °C. The voltage along the drift
section was set to 600 V leading to a reduced electric
field of approximately 130 Td. The spectral scans of
the TOF analyzer ranged from approximately m/z 2.7
up to m/z 500, and were acquired in a time of 250 ms
by co-adding 6250 single 40 μs TOF-MS extractions
recorded at a sampling frequency of 10 GHz. Themass
resolution obtained from the detected peaks (full
width at half maximum (FWHM))wasmeasured to be
approximately 4100 at m/z 100. Mass calibration was
based on three mass spectral peaks always present in
the spectra: H3
18O+ (21.0221), O2
+ (31.9893), and pro-
tonated acetoneC3H7O
+ (59.0491).
The compounds of interest were quantified using
the protonated parents of the prototypic VOCs.
2.4. Buffered end-tidal (BET) sampling
In the absence of a gold standard, it is very difficult to
validate the non-contact breath sampling developed
within this study. Nevertheless, an effort was made to
compare the results obtained during non-contact
sampling with another well-established breath sam-
plingmethod. For this purpose, a BET on-line sampler
(Ionicon Analytik GmbH) [15] was selected as it is
specifically designed for breath analysis with the PTR-
MS. Therefore the same analytical instrument (and its
settings) could be used for both sampling methods. In
short, the BET sampler consists of a heated (60 °C)
sampling buffer Teflon tube (30 cm long, 1.27 cm ID
(½ inch), and an approximate volume of 40 ml).
During sampling, a subject provides only one com-
plete exhalation via a disposable non re-breathing
mouthpiece into the buffer tube, in which the end-
tidal fraction of the exhalation is buffered. The tube
content is continuously drawn from the middle of the
buffer tube by the PTR-MS via a heated PEEK transfer
line (60 °C, 2 m long, ID=1 mm). Such an approach
increases the measurement time of a single exhalation
to 8–12 s, while preserving the advantages of the real-
time analysis. Effectively, subjects were requested to
provide 5 exhalations via the BET sampler and
subsequently 5 exhalations using the DW distant
sampling protocol, and the average signal resulting
from the individual compounds of interest was used
for the statistical analysis. The DW scenario was
chosen as it provided longer end-tidal phases and
effectively more measurement points for the PTR-MS
as it will be shown below. Moreover, to reduce the
differences between the compared sampling protocols,
individuals were asked to undertake a deep inhalation
without breath holding for the BET sampling.
3. Results
Exemplary PTR-MS profiles of acetone, methanol,
isoprene and DMS obtained for the five subsequent
DW exhalations and a blowing distance of approxi-
mately 2 cm are shown in figure 2. It should be
mentioned here, that the applied PTR-MS sampling
resolution assisted the identification of the dead-space
and end-tidal exhalation phases.
Exemplary dependences of breath levels of acet-
one, isoprene, DMS and methanol on sampling dis-
tance obtained for 2 subjects and DS scenario are
shown in figure 3. Not unexpectedly, considerable los-
ses were observed formore distant sampling points for
all tested scenarios. For instance, for the DS scenario at
a distance of 5 cm the concentrations of species of
interest dropped by approximately 30% as compared
to the levels obtained for 2 cm. At distances of 7.5 cm
and 10 cm from the volunteers’ lips the observed los-
ses were between 40% and 50% of the values observed
for the closest sampling point. It is also worth men-
tioning that for the larger distances (7.5–10 cm)
volunteers tended to exhale faster and stronger trying
to reach/target the inlet. This behavior shortened the
length of the exhalation and, thereby, the time avail-
able for sampling.
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As stated above, four sampling scenarios were
compared within this study. Comparisons were per-
formed for a sampling distance of approximately
2.0 cm, which ensured the lowest sample dilution by
the ambient air. Four parameters were taken into
account to compare the sampling scenarios of interest:
Figure 2.Exemplary breath profiles of acetone,methanol, isoprene andDMSobtained for a distance of 2.0 cm.
Figure 3.Exemplarydependences of breath levels of acetone, isoprene,DMSandmethanol on samplingdistance obtained for 2 subjects.
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(i) concentrations of preselected VOCs, (ii) reproduci-
bility of measurements, and (iii) lengths of the dead-
space and end-tidal phases of exhalation. An exemp-
lary exhalation profile obtained for acetone and theDS
breathing scenario is shown in figure 4. The typical
exhalation profile consists of three phases; (i) dead-
space phase, (ii) end-tidal phase and (iii) residual
phase. The dead-space phase corresponds to the exha-
lation of airfilling the upper air-ways and oral cavity. It
is characterized by a steady increase of concentrations
of blood-borne VOCs following the increasing
contribution of alveolar air. The end-tidal phase con-
tains air that has participated in the blood-air gas
exchange in the alveoli and, therefore, exhibits the
highest levels of blood-borne volatile markers. Typi-
cally, VOC concentration levels during this phase
exhibit a pseudo-plateau showing a mild increase
[14, 23]. The residual phase in turn consists of a mix-
ture of ambient air and remaining breath gas, which
stayed in the proximity of an inlet after the exhalations
have been finished. The boundaries between these
phases are not very evident and are therefore not easy
to define. For this study, the beginning of the dead-
space phase was determined by the PTR-MSmeasure-
ment point preceding the rapid increase of a VOC
level; whereas, its end was indicated by the measure-
ment point exhibiting the concentration of an analyte
corresponding to the 70% of its maximum level dur-
ing the end-tidal phase. This threshold of 70%, which
is arbitrarily chosen, is used also to determine the end
of the end-tidal phase of exhalation. Table 1 sum-
marizes the concentrations, signal reproducibility and
durations of dead space and end-tidal phases of
exhalation determined for the prototypic VOCs and
the 4 tested breathing scenarios.
The results of the BET and DW sampling scenario
comparison are presented in table 3.
4.Discussion
Within this study, valuable pieces of information were
extracted with regards to the behavior of the subjects
during non-contact sampling. First, a number of
individuals appeared to be distressed and experienced
a kind of anxiety during sampling, which was mani-
fested by distorted breathing patterns and a tendency
to shorten or slow down the exhalation and/or
inability to keep stable the direction of the breath
stream. Consequently, the resulting exhalation pro-
files of compounds of interest were distorted. This is
clearly illustrated in figure 5. These initial problems
are attributed to the lack of familiarity with breath
tests. However, this is dramatically reduced after 3–4
trial exhalations. Therefore, some practice of non-
contact sampling is necessary before real samples are
taken for analysis to give the subjects time to get use to
and comfortable with the breath sampling protocol.
Following this finding, all participants were advised to
perform several trial exhalations before the measure-
ments to help relax them. Next, the subjects tended to
interpret instructions concerning the inhalation
mode, blowing/exhalation mode, or size/shape of the
mouth opening in slightly different ways; thereby,
affecting the sampling. This problem seemed to stem
from the lack of unambiguously understandable terms
related to breathing. Interestingly, sampling protocols
Figure 4.Typical phases of the exhalation profile (acetone) obtained forDS breathingmode.
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were perceived by individual subjects differently. For
instance, blowing via a wide opening was described by
some subjects as being unpleasant. This blowingmode
required also more practice with respect to size and
shape of the mouth opening during blowing. Several
volunteers reported that deep inhalation was uncom-
fortable when performed consecutively.
To ensure the highest levels of breath VOCs and to
reduce the dilution of the breath gas with room air,
samples should be taken as close as possible from the
subject’s lips. Effectively, the distance of approxi-
mately 2 cm can be considered to be a reasonable
trade-off between the effect of breath dilution related
to distant sampling and the risk of the physical contact
Table 1.Concentrations, durations of the dead space and end-tidal phases of the exhalation and signal reproducibility levels (n=5) for the
volatile breath compounds under study obtained for tested breathing scenariosN–normal inhalation, D–deep inhalation, S–blowing via a









Methanol S N 244 (122–515) 8.4 (0.9–20) 1.3 (1.1–2.0) 2.0 (0.7–3.9)
D 286 (139–530) 9.7 (4.5–17.5) 1.6(1.0–2.5) 3.6 (1.1–8.6)
W N 272 (99–498) 5.6 (3.4–10.5) 1.37 (1.0–1.8) 1.8 (1.3–3.5)
D 285 (106–524) 7.8 (1.7–15.8) 1.7 (1.1–2.3) 2.6 (1.8–7.8)
Acetone S N 414 (201–710) 9.5(2.9–25.0) 1.6 (1.1–2.6) 1.5 (0.7–3.5)
D 527 (240–916) 9.6 (4.5–17) 2,0 (1.2–3.4) 3.0 (1.1–6.0)
W N 493 (156–932) 7.0 (1.5–10.5) 1.54 (1.0–2.0) 1.6 (1.1–3.0)
D 547 (177–997) 7.5 (1.7–19) 1.8 (1.3–2.4) 2.4 (1.5–7.3)
DMS S N 14.0 (2.6–42) 13.2 (1.7–25) 1.7 (1.0–2.5) 1.3 (0.4–3.0)
D 16.6 (2.5–54) 11.7 (5–25) 2.0 (1.0–3.3) 3.0 (0.6–6.7)
W N 18.4 (2.0–61) 12.3 (2.6–24.3) 1.5 (1.0–2.0) 1.3 (0.7–2.2)
D 17.4 (1.8–60) 8.5 (4.1–24) 1.75 (1.3–2.4) 2.0 (1.4–6.7)
Isoprene S N 149 (28–150) 12.0 (3.0–30) 1.3 (0.9–2.2) 1.6 (0.5–3.3)
D 143 (40–360) 13.4 (11–28) 1.7 (0.8–3.5) 2.5 (0.6–6.7)
W N 171 (37–383) 11.8 (4.6–24) 1.3 (0.8–1.5) 1.5 (0.9–2.9)
D 136 (32–348) 10.5 (3.1–19.5) 1.6 (1.0–2.4) 2.1 (1.3–6.3)
Average S N 10.9 1.4 1.5
D 11.1 1.8 2.9
W N 9.2 1.4 1.5
D 8.5 1.7 2.3
Figure 5.Exemplary acetone profiles obtained during a practicemeasurement. The first two exhalation profiles are distorted due to
the irregular breathing caused by stress.
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of the subject lips with the inlet material. Moreover,
some volunteers had difficulties in providing a reliable
sample for sampling distances larger than 5 cm owing
to problems related to a proper targeting of the breath
stream towards the inlet orifice. This finding implies
that sampling distances longer than 5 cm are of limited
use for the non-contact breath sampling protocol.
A review of table 1 reveals that the measured con-
centrations of the VOCs under study agree reasonably
well with the literature values [24–34]. A Wilcoxon
signed rank test was used to compare the VOCs’ con-
centrations obtained for different sampling scenarios
and a p value of<0.05was considered as significant (see
table 2). Concentrations of the two hydrophilic com-
pounds, i.e. methanol and acetone, were significantly
higher when deep inhalation was performed during the
breathing scenario. The observed differences amounted
to 15% and 19% for methanol and acetone, respec-
tively, for exhalation via a smaller mouth opening and
7% and 10.5% for blowing via a wide one. This differ-
ence is not surprising as blowing through a smaller lip
opening is longer and therefore causes a breath holding
effect. Such an effect was not observed for the hydro-
phobic species, for which levels were not significantly
altered by deep inhalation. The average reproducibility
(RSDs) ofmeasurements was spread around 10% for all
tested scenarios. Taking into consideration numerous
confounding factors, which can affect distant sampling,
this number can be considered to be very promising. It
is worth mentioning that blowing via a wider lip open-
ing provides better reproducibility (approximately 2%).
This improvement is attributed to the facilitated aiming
at the inlet while blowing with a larger breath stream.
The RSDs for DMS and isoprene were higher as com-
pared to acetone and methanol values. This difference
can stem from a higher reactivity in the case of DMS,
and for isoprene in terms of the known concentration
dependence on even small body movements. The
length of the dead-space phase of exhalation was influ-
enced mainly by the breathing mode. In the case of
normal inhalation this phase lasted on average for 1.4 s,
whereas, deep breathing extended it to 0.3–0.4 s. How-
ever, this difference can stem from the applied algo-
rithm of the dead-space phase identification. More
pronounced differences were recorded for the end-tidal
phase. Normal relaxed inhalation provided 1.5 s long
end-tidal phases in case of both blowing modes; while,
deep breathing prolonged this phase to approximately
3 s when the subject blew via a small opening, and 2.3 s
when the exhalation was performed via a wider one.
The shorter end-tidal phase for the latter scenario is not
surprising as widermouth opening increases the breath
streamdiameter and shortens the exhalation.
The comparison of the BET and non-contact sam-
plings was performed for a DW scenario as it provides
longer end-tidal phases of exhalation. The levels of
methanol, DMS and isoprene were found to be sig-
nificantly higher when samples were taken via the BET
sampler (Wilcoxon signed-rank test, p<0.05). This
difference was spread around 10% resulting most
probably from a minor dilution of breath by ambient
air during distant sampling. Both sampling methods
showed similar measurement reproducibility (RSDs)
varying from 3% to 15%. The only exception was
DMS, which exhibited twice the RSD in the case of dis-
tant sampling. This discrepancy can be attributed
to low breath concentrations of this species and
4–5 times shorter time to sample end-tidal phase of
exhalation during the DW distant sampling. In part-
icular, the latter affected strongly the quantification of
this species by the PTR-MS instrument. Relatively
high variability of isoprene levels reflects susceptibility
of its levels to even small bodymovements [10, 11].
5. Conclusions
In the context of rapid advances in breath gas analysis,
there is a need for adequate breath sampling methods
fulfilling the requirements of the new generation of the
miniaturized sensor-based breath analysers. This
Table 2.The outcome of aWilcoxon signed rank test and the concentration differences in (%) for tested sampling scenarios. N–normal
breathing, D–deep breathing, S–blowing via a smallmouth opening, andW–blowing via awidemouth opening.
(%) DWversusNS DWversusDS DWversusNW DS versusNS DS versusNW NS versusNW
Methanol 13 n.s. 7 15 n.s. n.s.
Acetone 17 n.s. 10.5 19 n.s. n.s.
DMS n.s. n.s. n.s. n.s. n.s. −16
Isoprene n.s. n.s. 22 n.s. n.s. n.s.
Table 3.Comparison of the BET sampler and theDWdistant sampling.D-deep inhalation andW–blowing via a widemouth
opening.
BETRSD (%) Distant sampling RSD (%) Relative concentration difference (CBET−CDW)/CBET
*100 (%)
Methanol 1.7 5.5 8.0
Acetone 4.3 5.0 1.0
DMS 6.7 15.2 11.0
Isoprene 11.3 13.0 12.5
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study has illustrated that a promising method is non-
contact sampling, i.e. a collection of breath samples by
exhalation from a distance without bringing the
mouth into direct contact with the device as a potential
breath sampling method. This is easier for the person
and reduces contamination issues. Within this study
two inhalation modes (normal, relaxed breathing and
deep breathing) and two exhalation types (quiet
blowing via small and wide lips opening without
breath holding) forming four breathing scenarios were
compared. All tested breathing scenarios exhibit
comparable measurement reproducibility spread
around 10%. In scenarios involving normal and
relaxed inspiration, both the dead-space and end-tidal
phases last around 1.5 s. Deep inhalation prolongs the
end-tidal phase by about a factor of 2 in the case of
blowing via a small lips opening, and by approximately
50%when the air is exhaled via a wide one. Moreover,
deep breathing increases the concentrations of hydro-
philic species by 9%–17%. Regarding sampling dis-
tance, a distance of 2 cm was found to be a reasonable
trade-off between the necessity of the reduction of the
sample dilution and requirement of no physical
contact of the subject with the instrument inlet.
Effectively, the non-contact sampling from a distance
of 2 cm causes 10% sample dilution as compared to
the BET sampling.
The main issue is the sampling system of the sen-
sor device, which should be able to provide adequate
amounts of the breath sample for the gas sensors. This
is in turn is hindered by the time available for sam-
pling. In this study, a 3 s alveolar phase provided
approximately 12 ml of breath gas (sampling rate of
4 ml s−1). This amount can be increased by using
more efficient micro pumps. Nevertheless, the final
selection on the optimal distant breath sampling pro-
tocol is determined by the technical specifications of
theminiaturized breath analyzer.
In practical terms, distant sampling offers distinct
advantages. Firstly, such a concept contributes to the
miniaturization of the breath analyzer and removes the
need for disposable mouthpieces. Secondly, breath can
be sampled during a breathing scenario, which is rela-
tively close to natural spontaneous breathing. Finally,
the sampling protocol is simple, convenient, safe and
easy to understand/learn for the user. In summary, dis-
tant non-contact breath sampling can be considered as
an interesting alternative to existing breath sampling
methods for usewithminiaturized breath analyzers.
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